These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13784154)

  • 21. THE USE OF RAT ASCITES TUMORS HETEROGRAFTED IN MICE FOR SCREENING OF ANTICANCEROUS AGENTS.
    HAGIHARA K
    Acta Pathol Jpn; 1963 Oct; 13():295-307. PubMed ID: 14195195
    [No Abstract]   [Full Text] [Related]  

  • 22. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 23. EFFECT OF HEAVY PARTICLES ON THE PROLIFERATIVE CAPACITY OF ASCITES TUMOR CELLS (LYMPHOMA) GROWN IN VIVO. UCRL-11833.
    SCHMIDLIN Y; LAWRENCE JH; SILLESEN K; WELCH G; LYMAN J
    UCRL US At Energy Comm; 1964; 36():80-94. PubMed ID: 24547366
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE EFFECT OF SUBCUTANEOUSLY ADMINISTERED SUPRASTIN ON ASCITES TUMOR STRAINS IN MICE].
    HONTI G; PUTNOKY G
    Z Gesamte Inn Med; 1963 Sep; 18():801-3. PubMed ID: 14095005
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the modification of Ehrlich ascites carcinoma in the mouse by isonicotinic acid hydrazide].
    SIEGEL D; IWAINSKY H
    Z Krebsforsch; 1960; 63():263-8. PubMed ID: 14446467
    [No Abstract]   [Full Text] [Related]  

  • 26. [COMPARATIVE EVALUATION OF SOME ANTITRICHOMONAS PREPARATIONS IN ANIMALS].
    LIUBIMOVA LK
    Antibiotiki; 1963 Aug; 8():741-4. PubMed ID: 14124732
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the influence of hydrogen peroxide on the metabolism of ascites tumor cells].
    PANTLITSCHKO M; SEELICH F
    Biochem Z; 1960; 333():78-83. PubMed ID: 14430189
    [No Abstract]   [Full Text] [Related]  

  • 28. [Daily periodic variations in the potency of the cancerostatic effect of nitrogen mustard oxide in Ehrlich ascites carcinoma in mice].
    POHLE K; MATTHIES E; MENG K
    Z Krebsforsch; 1961; 64():215-18. PubMed ID: 13736566
    [No Abstract]   [Full Text] [Related]  

  • 29. STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. I. FIBRINOLYTIC SYSTEM, ASCITES RETENTION AND INTRAPERITONEAL HEMORRHAGE IN TUMOR BEARING MICE: SUPPRESSING EFFECT OF EPSILON AMINOCAPROIC ACID.
    KINJO K; HIRATA T; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():151-60. PubMed ID: 14160535
    [No Abstract]   [Full Text] [Related]  

  • 30. TREATMENT OF EXPERIMENTAL ASCITES TUMORS WITH CRYSTALLINE RIBONUCLEASE.
    PODOLSKY S; WASE A; CARDENAS J
    Curr Ther Res Clin Exp; 1964 May; 6():387-93. PubMed ID: 14193773
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of chemotherapeutic agents against a variety of mouse ascites tumors. III.
    RUTMAN RJ; LEWIS FS; BUCKNER S; PRICE CC; LLEWELLYN F; OWEN E
    Cancer Res; 1962 Aug; 22():559-608. PubMed ID: 14495504
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE MORPHOLOGICAL EFFECT OF DIFFERENT CHEMOTHERAPEUTIC AGENTS ON DEGRANOL-SENSITIVE AND DEGRANOL-RESISTANT NK/LY ASCITES TUMOR].
    GATI E
    Z Krebsforsch; 1965 Feb; 66():460-5. PubMed ID: 14263006
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of potential radiosensitizing agents: an effect of tetrasodium 2-methyl-1:4-naphthohydroquinone diphosphate (synkavit) on the Ehrlich mouse ascites tumour.
    MARRIAN DH
    Br J Cancer; 1959 Sep; 13(3):461-8. PubMed ID: 13848612
    [No Abstract]   [Full Text] [Related]  

  • 34. IMMUNITY AND CROSS-IMMUNITY IN MICE BEARING SARCOMA 180-CROCKER AND THE SOLID FORM OF EHRLICH-ASCITES CURED BY ANTIBIOTICUM BULGARICUM.
    BOGDANOV I; POPCHRISTOV P; MARINOV L
    Acta Unio Int Contra Cancrum; 1964; 20():293-4. PubMed ID: 14151912
    [No Abstract]   [Full Text] [Related]  

  • 35. The in vitro effect of various enzymes upon the mouse ascites tumor of Ehrlich.
    STECKERL F; OFODILE A; CAMPBELL RR; TURNER ML; FRIEDELL GH
    Experientia; 1961 Nov; 17():509-10. PubMed ID: 13916476
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of carnitine and thyroxin on mouse ascites tumor].
    STRACK E; FUCHS U; ROTZSCH W
    Acta Biol Med Ger; 1961; 7():563-76. PubMed ID: 13917585
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of carcinogens and related compounds on the growth of Ehrlich ascites carcinoma and its possible mechanism.
    HRADEC J
    Br J Cancer; 1959 Jun; 13(2):336-47. PubMed ID: 14403540
    [No Abstract]   [Full Text] [Related]  

  • 38. THE DPN CONTENT OF MITOCHONDRIA ISOLATED FROM ASCITES- TUMOUR CELLS TREATED WITH A CARCINOSTATIC ETHYLENEIMINE.
    BORST P; GRIMBERG H; HOLZER H
    Biochim Biophys Acta; 1963 Sep; 74():785-7. PubMed ID: 14078946
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on methods for the determination of anti-tumor properties of antibiotics and synthetic preparations. I. A rapid method of primary selection of Ehrlich ascites carcinoma cell inhibitors in vitro].
    AIZENMAN BIu; MANDRIK TP; SHVAIGER MO
    Mikrobiol Zh; 1959; 21(2)():49-56. PubMed ID: 13792221
    [No Abstract]   [Full Text] [Related]  

  • 40. CYTOCIDAL EFFECTS OF MITOMYCIN-C ON MH-134 ASCITES TUMOR CELLS IN VITRO.
    HATTORI T; ENDO S
    Jpn J Exp Med; 1964 Jun; 34():153-7. PubMed ID: 14192593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.